Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Sundial Growers
SNDL
$311M
| $133K | ﹤0.01% |
+20,750
| New | +$354K |
|
3177
Forum Energy Technologies
FET
$927M
| $132K | ﹤0.01% |
37,271
+8,489
| +29% | +$157K |
|
3178
Lipocine
LPCN
$17M
| $132K | ﹤0.01% |
16,183
-95,656
| -86% | -$757K |
|
3179
Ranger Energy Services
RNGR
$405M
| $131K | ﹤0.01% |
32,287
+2,801
| +9% | +$17.2K |
|
|
NBRV
3180
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $131K | ﹤0.01% |
910
-3,409
| -79% | -$1.04M |
|
|
NINE
3181
DELISTED
Nine Energy Service
NINE
| $130K | ﹤0.01% |
160,700
+50,500
| +46% | +$228K |
|
3182
Aehr Test Systems
AEHR
$4.02B
| $129K | ﹤0.01% |
77,299
-301
| -0.4% | -$581 |
|
3183
Destination XL Group
DXLG
$33.2M
| $128K | ﹤0.01% |
365,811
+150,523
| +70% | +$132K |
|
3184
Arcadia Biosciences
RKDA
$1.24M
| $126K | ﹤0.01% |
+1,102
| New | +$192K |
|
3185
BayCom
BCML
$339M
| $125K | ﹤0.01% |
10,400
-34,700
| -77% | -$693K |
|
3186
Capricor Therapeutics
CAPR
$244M
| $124K | ﹤0.01% |
103,615
+19,830
| +24% | +$27.7K |
|
3187
Carter Bankshares
CARE
$757M
| $124K | ﹤0.01% |
+13,487
| New | +$230K |
|
3188
Fulgent Genetics
FLGT
$513M
| $124K | ﹤0.01% |
11,521
-76,900
| -87% | -$1.07M |
|
3189
International Money Express
IMXI
$353M
| $124K | ﹤0.01% |
+13,615
| New | +$143K |
|
|
MCF
3190
DELISTED
Contango Oil & Gas Co.
MCF
| $123K | ﹤0.01% |
+82,066
| New | +$258K |
|
3191
Xenetic Biosciences
XBIO
$7.54M
| $122K | ﹤0.01% |
16,412
+4,332
| +36% | +$50.3K |
|
|
REV
3192
DELISTED
Revlon, Inc.
REV
| $122K | ﹤0.01% |
+11,196
| New | +$205K |
|
|
APM
3193
DELISTED
Aptorum Group
APM
| $121K | ﹤0.01% |
+3,304
| New | +$339K |
|
|
SOLO
3194
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $121K | ﹤0.01% |
+116,153
| New | +$215K |
|
|
DX
3195
Dynex Capital
DX
$3.23B
| $120K | ﹤0.01% |
+11,500
| New | +$190K |
|
3196
DSS Inc
DSS
$5.18M
| $118K | ﹤0.01% |
1,067
+1,012
| +1,840% | +$139K |
|
|
CARM
3197
DELISTED
Carisma Therapeutics
CARM
| $117K | ﹤0.01% |
+10,411
| New | +$171K |
|
|
MTL.PR
3198
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $117K | ﹤0.01% |
334,802
+9,202
| +3% | +$6.38K |
|
|
PPBT
3199
Purple Biotech
PPBT
$2.44M
| $116K | ﹤0.01% |
+189
| New | +$232K |
|
3200
US Global Investors
GROW
$38.8M
| $115K | ﹤0.01% |
118,326
+14,500
| +14% | +$17.7K |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.